Recommendations for follow up in castration resistant prostate cancer

被引:0
|
作者
Vazquez-Alonso, Fernando [1 ]
Puche-Sanz, Ignacio [1 ]
Manuel Cozar-Olmo, Jose [1 ]
机构
[1] Hosp Univ Virgen Nieves, UGC Urol, Avda Fuerzas Armadas 2, Granada 18014, Spain
来源
ARCHIVOS ESPANOLES DE UROLOGIA | 2018年 / 71卷 / 08期
关键词
Prostate cancer; Diagnosis; Follow up; Castration resistance; Metastases; CLINICAL-TRIALS; FREE SURVIVAL; PHASE-II; ENZALUTAMIDE; ABIRATERONE; GUIDELINES; DISEASE; DESIGN; PET/CT; MEN;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: There is no broad consensus about what diagnostic tests use for CRPC follow up as well as their frequency. Our objective is to review and analyze the most important CRPC follow up patterns described in the literature to date. METHODS: We performed a critical analysis of the recommendations for follow up most universally employed (PCWG3, RADAR, St Gallen consensus, NCCN guidelines, EAU guidelines) RESULTS: CT scan and bone scan are the routine recommended diagnostic tests, in front of other techniques such as PET/CT or MRI, that may improve the diagnostic efficacy but they have the problem of availability and lack of internal validity for follow up. CONCLUSIONS: Follow up is different for non metastatic and metastatic CRPC. For nm CRPC, it is recommended to perform monitoring that includes PSA and imaging tests, without consensus about periodicity. For mCRPC, it is recammendable to do follow up with periodic PSA and imaging tests, since it is possible to have radiological progression without PSA progression.
引用
收藏
页码:735 / 742
页数:8
相关论文
共 50 条
  • [1] Castration-Resistant Prostate Cancer An Algorithmic Approach
    Stratton, Kelly
    Cookson, Michael
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (04) : 647 - 655
  • [2] Non-metastatic castration-resistant prostate cancer: management recommendations
    Alcaraz Asensio, A.
    Alvarez Ossorio, J. L.
    Cozar Olmo, J. M.
    Chantada Abal, V
    Juarez Soto, A.
    Espinos, E. Linares
    Moreno Jimenez, J.
    Munoz Rodriguez, J.
    Perez Fentes, D.
    Plata Bello, A.
    Rodrigo Aliaga, M.
    Unda Urzaiz, M.
    Vilaseca, A.
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (04): : 193 - 213
  • [3] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [4] Current management of advanced and castration resistant prostate cancer
    Gomella, Leonard G.
    Petrylak, Daniel P.
    Shayegan, Bobby
    CANADIAN JOURNAL OF UROLOGY, 2014, 21 : 1 - 6
  • [5] Corticotherapy in castration-resistant prostate cancer
    Lebdai, S.
    Branchereau, J.
    Robert, G.
    De La Tallie, A.
    Bouchaert, P.
    PROGRES EN UROLOGIE, 2013, 23 : S23 - S33
  • [6] Castration Resistant Prostate Cancer 2015
    Merseburger, A. S.
    Boeker, A.
    Kuczyk, M. A.
    von Klot, C. -A.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 59 - 65
  • [7] EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
    Heidenreich, Axel
    Bastian, Patrick J.
    Bellmunt, Joaquim
    Bolla, Michel
    Joniau, Steven
    van der Kwast, Theodor
    Mason, Malcolm
    Matveev, Vsevolod
    Wiegel, Thomas
    Zattoni, Filiberto
    Mottet, Nicolas
    EUROPEAN UROLOGY, 2014, 65 (02) : 467 - 479
  • [8] Monitoring of treatment for metastatic castration-resistant prostate cancer
    Hinz, Stefan
    AKTUELLE UROLOGIE, 2017, 48 (03) : 225 - 229
  • [9] Consensus on castration-resistant prostate cancer management in Spain
    Alcaraz, Antonio
    Martinez-Pineiro, Luis
    Rodriguez, Alfredo
    Rubio, Jose
    Borque, Angel
    Burgos, Javier
    Carballido, Joaquin
    Manuel Cozar, Jose
    Crespo, Itziar
    Esquenaw, Salvador
    Gomez-Veiga, Francisco
    Lopez, Dionisio
    Minana, Bernardino
    Morote, Juan
    Jose Ribal, Maria
    Solsona, Eduardo
    Francisco Suarez, Jose
    Unda, Miguel
    ARCHIVOS ESPANOLES DE UROLOGIA, 2017, 70 (09): : 777 - 791
  • [10] The changing landscape in metastatic castration-resistant prostate cancer
    Leibowitz-Amit, Raya
    Joshua, Anthony M.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 243 - 248